ANTI-CCP2 QUARTILE COMPARISON OF THE COST PER RESPONSE FOR ABATACEPT COMPARED TO ADALIMUMAB BASED ON AMPLE IN THE UNITED STATES
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1146
https://www.valueinhealthjournal.com/article/S1098-3015(16)01214-6/fulltext
Title :
ANTI-CCP2 QUARTILE COMPARISON OF THE COST PER RESPONSE FOR ABATACEPT COMPARED TO ADALIMUMAB BASED ON AMPLE IN THE UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01214-6&doi=10.1016/j.jval.2016.03.1146
First page :
A233
Section Title :
Muscular-Skeletal Disorders - Cost Studies
Open access? :
No
Section Order :
825